Redhill Biopharma
RDHL
#10410
Rank
โ‚น0.51 B
Marketcap
โ‚น101.14
Share price
-2.61%
Change (1 day)
-80.22%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -โ‚น53,915

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -โ‚น63,210. In 2017 the company made an earnings per share (EPS) of -โ‚น2,25,750 a decrease over its 2016 EPS that were of -โ‚น1,98,660.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น53,915
2017-โ‚น2,25,75013.64%
2016-โ‚น1,98,6609.12%
2015-โ‚น1,82,05368.01%
2014-โ‚น1,08,360-25.93%
2013-โ‚น1,46,286

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น334.62-100.53%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น685.72-101.08%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น324.71-100.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น56.89-100.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚น110.17-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel